Ipamorelin is a growth-hormone secretagogue described as selective because it caused less cortisol and prolactin release in animal studies. Human development focused on postoperative bowel recovery and did not show clear benefit.
Key points
- Selectivity findings come from animal pharmacology.
- Human trials investigated postoperative ileus, with mixed results.
- No controlled trial measured muscle or fat-loss outcomes.
- Products sold online under this name have not been independently verified; label identity and concentration cannot be assumed.
What the literature shows
Raun and colleagues characterised ipamorelin in swine and rats, reporting GH release without marked ACTH or cortisol increases.
A phase II trial in bowel-resection patients did not demonstrate a significant benefit on the primary recovery endpoint.
What remains unknown
- Long-term endocrine effects in healthy adults.
- Whether selectivity holds at higher recreational exposure.
Safety and monitoring implications
- Appetite, fluid retention and glucose changes are plausible GH-axis effects.
- Use outside supervision removes monitoring of IGF-1 and glucose.
Cited literature
- 1.Raun K, Hansen BS, Johansen NL, et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. Find on PubMed
- 2.Beck DE, Sweeney WB, McCarter MD, et al. (2014). Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. International Journal of Colorectal Disease. Find on PubMed
Community reports
Anecdotal — not scientific evidence
Lived experience is valuable context and often surfaces problems before the literature does. It is also uncontrolled, unverified and subject to bias, so it never overrides published findings here.
Editorial evidence status
MixedCommunity discussion of this compound is widespread, but no independently verified reports were available for this analysis. Anecdotes have not been invented or treated as clinical evidence.
Buying Ipamorelin in Australia: what to check first
APEDRA does not sell Ipamorelin or any other product, and takes no commission from suppliers. If you are researching where to buy it, the biggest practical risk is not the compound itself but what is actually in the bottle: under-dosing, substitution with a different compound, and contamination are all documented in independent testing of online research chemicals.
- Ask for a batch-specific third-party lab report (HPLC/mass spectrometry), not a generic certificate.
- Check independent review platforms, not only reviews hosted on the seller's own site.
- Read the shipping, returns and refund policies before ordering.
- Be wary of prices far below the market or exaggerated results claims.
Compare Australian vendors independently · how we assess suppliers
Terms used here are defined in our glossary, and the evidence-grading scale explains what this analysis's grade means. If you believe something here is wrong, tell us.
This analysis is educational. It is not medical advice, a dosing recommendation, or an endorsement of use. Speak with a qualified medical practitioner about your circumstances.